Paper7901434
Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients.
Sande MA and 4 others. JAMA, 1993. Cited by 139 papers, by iCite.
Cite this record
ConductScience Library. Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. Papers, record 7901434. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7901434
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dideoxynucleosides | Major topic |
| HIV Infections | Major topic |
| Adult | |
| CD4-Positive T-Lymphocytes | |
| Clinical Trials as Topic | |
| Didanosine | |
| Drug Resistance | |
| Guidelines as Topic | |
| Humans | |
| Leukocyte Count | |
| Zalcitabine | |
| Zidovudine |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 7515116 | NIAID recommendations for treating HIV infection. | https://conductscience.org/library/papers/7515116 |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26442227 | Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study. | CMAJ Open | 2015 | https://conductscience.org/library/papers/26442227 | PubMed |
| 18476047 | Human immunodeficiency virus type 1 counseling and testing program in the prenatal setting. | Infect Dis Obstet Gynecol | 1995 | https://conductscience.org/library/papers/18476047 | PubMed |
| 11658016 | Statistics and ethics in medical research. | Sci Eng Ethics | 1999 | https://conductscience.org/library/papers/11658016 | PubMed |
| 9517872 | Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy. | Eur J Epidemiol | 1998 | https://conductscience.org/library/papers/9517872 | PubMed |
| 9276664 | Effect of subspecialty training and experience on agreement with HIV guidelines. | J Gen Intern Med | 1997 | https://conductscience.org/library/papers/9276664 | PubMed |
| 9127225 | Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy. | J Gen Intern Med | 1997 | https://conductscience.org/library/papers/9127225 | PubMed |
| 8884187 | Quality of life assessment and HIV infection: a review. | Eur J Epidemiol | 1996 | https://conductscience.org/library/papers/8884187 | PubMed |
| 8879972 | Treatment of HIV infection. Tolerability of commonly used antiretroviral agents. | Drug Saf | 1996 | https://conductscience.org/library/papers/8879972 | PubMed |
| 8595267 | Managing HIV disease after Delta. | BMJ | 1996 | https://conductscience.org/library/papers/8595267 | PubMed |
| 8593022 | Strategies for control of zidovudine concentrations in serum. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/8593022 | PubMed |
| 8583491 | Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users. | J Natl Med Assoc | 1996 | https://conductscience.org/library/papers/8583491 | PubMed |
| 8562291 | Zidovudine therapy in HIV infection: which patients should be treated and when. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/8562291 | PubMed |
| 7744265 | AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter? | Genetica | 1995 | https://conductscience.org/library/papers/7744265 | PubMed |
| 7614902 | Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop. | Drugs | 1995 | https://conductscience.org/library/papers/7614902 | PubMed |
| 7574530 | Pharmacokinetics of clarithromycin and zidovudine in patients with AIDS. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7574530 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7901434
GET https://conductscience.org/api/papers/v1/7901434/authors